Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative Bacteria

Documenti analoghi

• Dosing of Aminoglycosides To Rapidly Attain Pharmacodynamic Goals and Hasten Therapeutic Response by Using Individualized Pharmacokinetic Monitoring of Patients with Pneumonia Caused by Gram-Negative Organisms
  di: Kashuba, A. D. M., et al.
  Pubblicazione: (1998)
• Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
  di: Rouby, J. J., et al.
  Pubblicazione: (2020)
• Polymyxin B Nephrotoxicity and Efficacy against Nosocomial Infections Caused by Multiresistant Gram-Negative Bacteria
  di: Ouderkirk, John P., et al.
  Pubblicazione: (2003)
• Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
  di: Rouby, J. J., et al.
  Pubblicazione: (2020)
• Spectrum of Aminoglycoside Modifying Enzymes in Gram-Negative Bacteria Causing Human Infections
  di: Lalitha Aishwarya, Kayanam Vijaya, et al.
  Pubblicazione: (2020)